Search

Author/Creator Kavanagh, J. J.

6. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Issue 4 (1st June 2005)

Authors:
Tangjitgamol, S.; Ramirez, P. T.; Sun, C. C.; See, H. T.; Jhingran, A.; Kavanagh, J. J.; Deavers, M. T.
Journal:
International journal of gynecological cancer
Issue:
Volume 15:Issue 4(2005)
Page Start:
646
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer. Issue 4 (1st June 2005)

Authors:
Kavanagh, J. J.; Gershenson, D. M.; Choi, H.; Lewis, L.; Patel, K.; Brown, G. L.; Garcia, A.; Spriggs, D. R.
Journal:
International journal of gynecological cancer
Issue:
Volume 15:Issue 4(2005)
Page Start:
593
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗